Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
900 results:
1. CircPDE5A-encoded novel regulator of the PI3K/akt pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract] [Full Text] [Related]
2. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
Xu L; Chen Y; Liu L; Hu X; He C; Zhou Y; Ding X; Luo M; Yan J; Liu Q; Li H; Lai D; Zou Z
PLoS Genet; 2024 Apr; 20(4):e1011235. PubMed ID: 38648200
[TBL] [Abstract] [Full Text] [Related]
4. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
[TBL] [Abstract] [Full Text] [Related]
5. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/akt/mTOR pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract] [Full Text] [Related]
6. Ropivacaine as a novel akt1 specific inhibitor regulates the stemness of breast cancer.
Ding L; Jiang H; Li Q; Li Q; Zhang TT; Shang L; Xie B; Zhu Y; Ding K; Shi X; Zhu T; Zhu Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):90. PubMed ID: 38523299
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma.
Duan Y; Zhou M; Ye B; Yue K; Qiao F; Wang Y; Lai Q; Wu Y; Cao J; Wu Y; Wang X; Jing C
Cell Death Dis; 2024 Mar; 15(3):215. PubMed ID: 38485986
[TBL] [Abstract] [Full Text] [Related]
8. Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the akt signaling pathway.
He L; She C; Jiang S; Qi Z; Deng Z; Ji L; Cui Y; Wu J
Biol Direct; 2024 Mar; 19(1):21. PubMed ID: 38459605
[TBL] [Abstract] [Full Text] [Related]
9. SORBS1 inhibits epithelial to mesenchymal transition (EMT) of breast cancer cells by regulating PI3K/akt signaling and macrophage phenotypic polarization.
Feng K; Di Y; Han M; Yan W; Wang Y
Aging (Albany NY); 2024 Mar; 16(5):4789-4810. PubMed ID: 38451194
[TBL] [Abstract] [Full Text] [Related]
10. GSG2 promotes thyroid cancer via stabilizing AURKB and activating akt pathway.
Zhang F; Huang C
Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
[TBL] [Abstract] [Full Text] [Related]
11. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract] [Full Text] [Related]
12. The interplay of PTEN and akt nexus in breast cancer: a molecular perspective.
Kamal A; Awan AR; Rabbani M; Sheikh HR; Tayyab M; Firyal S; Khan IH; Wasim M
Mol Biol Rep; 2024 Feb; 51(1):345. PubMed ID: 38400870
[TBL] [Abstract] [Full Text] [Related]
13. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/akt activation in a ceRNA manner.
Zhang C; Yu Z; Yang S; Liu Y; Song J; Mao J; Li M; Zhao Y
Mol Cancer; 2024 Feb; 23(1):33. PubMed ID: 38355583
[TBL] [Abstract] [Full Text] [Related]
14. GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/akt/mTOR pathway.
Zhang W; Tang X; Peng Y; Xu Y; Liu L; Liu S
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38334171
[TBL] [Abstract] [Full Text] [Related]
15. The emerging role of noncoding RNAs in the PI3K/akt/mTOR signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract] [Full Text] [Related]
16. Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the akt-S6 signaling.
Chen X; Meng C; Wang X; Wu Z; Sun X; Sun C; Zheng L; Li W; Jia W; Tang T
J Cancer Res Clin Oncol; 2024 Feb; 150(2):69. PubMed ID: 38305920
[TBL] [Abstract] [Full Text] [Related]
17. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract] [Full Text] [Related]
18. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
19. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
Nie J; Dang S; Zhu R; Lu T; Zhang W
Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
[TBL] [Abstract] [Full Text] [Related]
20. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
[Next]
